Pharmacosmos Email Format
Pharmaceutical ManufacturingZealand, Denmark201-500 Employees
Pharmacosmos A/S is a Danish pharmaceutical manufacturing company with a focus on carbohydrate chemistry and iron metabolism-related treatments for iron deficiency and iron deficiency anaemia. The company is headquartered in Holbæk, Zealand, Denmark, at 30 Roervangsvej, and employs 201-500 people. Founded in 1965, Pharmacosmos has international activities across the UK, Ireland, the Nordic region, Germany, the USA, Canada, and China. It has pursued partnerships and regional expansions, including a Kedrion Biopharma collaboration in 2022 to make Monoferric available in Italy, the sale of MonoFerric rights to Zydus for India and Nepal in 2022, and an Ontario expansion in 2026. Reported revenue is in the range of $250 million to $500 million.